Literature DB >> 33876738

Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis: A Meta-analysis of Randomized Clinical Trials.

X Xiao1, L Lin1, C Zhu1, X Yang1, Y Ni1, L Zhipeng1, J Chong2, Y Han1.   

Abstract

Entities:  

Keywords:  Atopic dermatitis; Efficacy; Meta-analysis; Nemolizumab; Safety

Year:  2021        PMID： 33876738     DOI： 10.18176/jiaci.0672

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  1 in total

1.  Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study.

Authors:  Diego Alvarado; Marcus Maurer; Richard Gedrich; Scott B Seibel; Michael B Murphy; Linda Crew; Joel Goldstein; Andrea Crocker; Laura A Vitale; Pamela A Morani; Lawrence J Thomas; Thomas R Hawthorne; Tibor Keler; Diane Young; Elizabeth Crowley; Martin Kankam; Margo Heath-Chiozzi
Journal:  Allergy       Date:  2022-03-03       Impact factor: 14.710
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.